Varvara Polydoropoulou

A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

Sanjay Popat, Alessandra Curioni‐Fontecedro, Urania Dafni et al. · Annals of Oncology · 2020 · 265 citations · Full text

Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab

Sherene Loi, Urania Dafni, Dimitris Karlis et al. · JAMA Oncology · 2016 · 93 citations · Full text

Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project

Igor Letovanec, Stephen P. Finn, Panagiota Zygoura et al. · Journal of Thoracic Oncology · 2017 · 84 citations · Full text

Advanced Lung Disease, European Nsclc Patients, Medicine +9

A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

Sanjay Popat, Alessandra Curioni‐Fontecedro, Varvara Polydoropoulou et al. · Annals of Oncology · 2019 · 54 citations · Full text

Oncology, Phase Iii Trial, Clinical Trials +7

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project

Keith M. Kerr, Urania Dafni, Katja Schulze et al. · Annals of Oncology · 2017 · 49 citations · Full text

Multiplex Mutation, Medicine, Genetics +8